Cloning, expression and biological activity of equine interleukin (IL)-5

Veterinary Immunology and Immunopathology

Volumn 95, Issue 1-2, 2003, Pages 63-72

  Cunningham, F M ^a   Vandergrifft, E ^b   Bailey, S R ^a   Sepulveda, M F ^a   Goode, N T ^a,c   Horohov, D W ^b  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

^b LOUISIANA STATE UNIVERSITY   (United States)

^c NONE   (United Kingdom)

Author keywords

Adherence; Eosinophil; Horse; Interleukin (IL) 5; Superoxide

Indexed keywords

CYTOCHROME C; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; RECOMBINANT INTERLEUKIN 5; RECOMBINANT PROTEIN; SUPEROXIDE;

ADHERENT CELL; ALLERGIC DISEASE; AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CELL STIMULATION; CHO CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; DNA SEQUENCE; DRUG ACTIVITY; DRUG INHIBITION; GENETIC SIMILARITY; GENETIC TRANSFECTION; HORSE; LYMPHOCYTE ACTIVATION; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; ORTHOLOGY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

BOVINAE; CRICETINAE; CRICETULUS GRISEUS; EQUIDAE; EQUUS CABALLUS; FELIDAE; MURINAE; OVIS;

EID: 0041836044     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2427(03)00100-4     Document Type: Article

References (37)

1. Adachi T., Alam R. The mechanism of IL-5 signal transduction. Am. J. Physiol. 275:1998;C623-C633.
2. Altschul S.F., Gish W., Miller W., Myers E.W., Lipman D.J. Basic local alignment search tool. J. Mol. Biol. 215:1990;403-410.
3. Bailey S.R., Cunningham F.M. Adherence of eosinophils from allergic and normal ponies to cultured equine endothelial cells. Inflamm. Res. 50:2001;32-38.
4. Bailey S.R., Cunningham F.M. Inflammatory mediators induce endothelium-dependent adherence of equine eosinophils to cultured endothelial cells. J. Vet. Pharmacol. Ther. 24:2001;209-214.
5. Beadle R., Gaunt S., Horohov D.W. Interleukin-4 and interferon-gamma gene expression in summer pasture-associated obstructive pulmonary disease in affected horses. Equine Vet. J. 34:2002;389-394.
6. Benarafa C., Cunningham F.M., Hamblin A.S., Horohov D., Collins M.E. Cloning of equine chemokines eotaxin, monocyte chemoattractant protein (MCP)-1, MCP-2 and MCP-4, mRNA expression in tissues and induction by IL-4 in dermal fibroblasts. Vet. Immunol. Immunopathol. 76:2000;283-298.
7. Benarafa C., Collins M.E., Hamblin A.S., Cunningham F.M. A role for the chemokine eotaxin in the pathogenesis of equine sweet itch. Vet. Rec. 151:2002;691-693.
8. Dickason R.R., English J.D., Huston D.P. Engineering of a functional interleukin-5 monomer: a paradigm for redesigning helical bundle cytokines with therapeutic potential in allergy and asthma. J. Mol. Med. 74:1996;535-546.
9. Ezeamuzie C.I., Al-Hage M. Differential effects of salbutamol and salmeterol on human eosinophil responses. J. Pharmacol. Exp. Ther. 284:1998;25-31.
10. Foster A.P., Cunningham F.M. Differential superoxide anion generation by equine eosinophils and neutrophils. Vet. Immunol. Immunopathol. 59:1997;225-237.
11. Foster, A.P., Cunningham, F.M., 1998a. The pathogenesis and immunopharmacology of equine insect hypersensitivity. In: Kwochka, K.W., Willemse, T., von Tscharner, C. (Eds.), Adv. Vet. Dermatol., vol. 3, pp. 177-189.
12. Foster A.P., Cunningham F.M. Histamine-induced adherence and migration of equine eosinophils. Am. J. Vet. Res. 59:1998;1153-1159.
13. Foster A.P., Lees P., Cunningham F.M. Platelet activating factor mimics antigen-induced cutaneous inflammatory responses in sweet itch horses. Vet. Immunol. Immunopathol. 44:1995;115-128.
14. Foster A.P., McCabe P.J., Sanjar S., Cunningham F.M. Agonist-induced adherence of equine eosinophils to fibronectin. Vet. Immunol. Immunopathol. 56:1997;205-220.
15. Foster A.P., McKelvie J., Cunningham F.M. The histamine-1 receptor antagonist chlorpheniramine inhibits antigen-induced cutaneous inflammatory responses in ponies with insect hypersensitivity. Vet. Rec. 143:1998;189-193.
16. Giguere S., Prescott J.F. Quantitation of equine cytokine mRNA expression by reverse transcription-competitive polymerase chain reaction. Vet. Immunol. Immunopathol. 67:1999;1-15.
17. Gleich G.J. Mechanisms of eosinophil-associated inflammation. J. Allergy Clin. Immunol. 105:2000;651-663.
18. Horie S., Gleich G.J., Kita H. Cytokines directly induce degranulation and superoxide production from human eosinophils. J. Allergy Clin. Immunol. 98:1996;371-381.
19. Kaufman R., Sharp P. Amplification and expression of sequences cotransfected with a modular dihydrofolate reductase complementary DNA gene. J. Mol. Biol. 159:1982;601-621.
20. Kodama S., Endo T., Tsujimoto M., Kobata A. Characterization of recombinant murine interleukin 5 expressed in Chinese hamster ovary cells. Glycobiology. 2:1992;419-427.
21. Koenderman L., van der Bruggen T., Schweizer R.C., Warringa R.A.J., Coffer P., Caldenhoven E., Lammers J.-W.J., Raaijmakers J.A.M. Eosinophil priming by cytokines: from cellular signal to in vivo modulation. Eur. Respir. J. 9(Suppl. 2):1996;119s-125s.
22. Kurotaki T., Narayama K., Oyamada T., Yoshikawa H., Yoshikawa T. Immunopathological study on equine insect hypersensitivity ('Kasen') in Japan. J. Comp. Pathol. 110:1994;145-152.
23. Lavoie J.P., Maghni K., Desnoyers M., Taha R., Martin J.G., Hamid Q.A. Neutrophilic airway inflammation in horses with heaves is characterised by a Th2-type cytokine profile. Am. J. Respir. Crit. Care Med. 164:2001;1410-1413.
24. McKelvie J., Foster A.P., Cunningham F.M., Hamblin A.S. Characterisation of lymphocyte subpopulations in the skin and circulation of horses with sweet itch (Culicoides hypersensitivity). Equine Vet. J. 31:1999;466-472.
25. McKenzie A.N., Ely B., Sanderson C.J. Mutated interleukin-5 monomers are biologically inactive. Mol. Immunol. 28:1991;155-1558.
26. Riek R.F. Studies on allergic dermatitis (Queensland Itch) of the horse. I. Description, distribution, symptoms and pathology. Aust. Vet. J. 29:1953;177-184.
27. Robinson N.E., Derksen F.J., Olszewski M.A., Beuchner-Maxwell V.A. The pathogenesis of chronic obstructive pulmonary disease of horses. Br. Vet. J. 152:1996;283-306.
28. Scott C.W., Budzilowicz C., Hubbs S.J., Stein M., Sobotka-Briner C., Wilkins D.E. Expression and in vitro properties of guinea pig IL-5: comparison to human and murine orthologs. Mediat. Inflamm. 9:2000;181-187.
29. Stevenson L.M., McInnes C.J., Haig D.McK., Jones D.G. Eosinophil-specific biological activity of recombinant ovine interleukin-5. Vet. Immunol. Immunopathol. 66:1998;359-365.
30. Swiderski C.E., Klei T.R., Folsom R.W., Pourciau S.S., Chapman A., Chapman M.R., Moore R.M., McClure J.R., Taylor H.W., Horohov D.W. Vaccination against Strongylus vulgaris in ponies: comparison of the humoral and cytokine responses of vaccinates and nonvaccinates. Adv. Vet. Med. 41:1999;389-404.
31. Swiderski C.E., Sobol G., Lunn D.P., Horohov D.W. Molecular cloning, sequencing, and expression of equine interleukin-6. Vet. Immunol. Immunopathol. 77:2000;213-220.
32. Sylvin H., Matvienko O., Leonchiks A., Alving K., van der Ploeg I. Molecular cloning, expression, and purification of pig interleukin-5. Immunogenetics. 51:2000;59-64.
33. Tanaka Y., Delaporte E., Dubucquoi S., Gounni A.S., Porchet E., Capron A., Capron M. Interleukin-5 messenger RNA and immunoreactive protein expression by activated eosinophils in lesional atopic dermatitis skin. J. Invest. Dermatol. 103:1994;589-592.
34. Tominaga A., Takahashi T., Kikuchi Y., Mita S., Naomi S., Harada N., Yamaguchi N., Takatsu K. Role of carbohydrate moiety of IL-5. Effect of tunicamycin on the glycosylation of IL-5 and the biologic activity of deglycosylated IL-5. J. Immunol. 144:1990;1345-1352.
35. Vandergrifft E.V., Horohov D.W. Molecular cloning and expression of equine interleukin 2. Vet. Immunol. Immunopathol. 39:1993;395-406.
36. Vandergrifft E.V., Swiderski C.E., Horohov D.W. Molecular cloning and sequencing of equine interleukin 4. Vet. Immunol. Immunopathol. 40:1994;379-384.
37. Weltman J.K., Karim A.S. IL-5: biology and potential therapeutic applications. Expert Opin. Invest. Drugs. 9:2000;491-496.